Stem Cells Advancement and Applications: A Regenerative Medicines

Innovative advancements in stem cell research have led to the development of organoids that serve as in vitro models for human organ development and disease studies. Developments in the culture of human pluripotent stem cells (hPSCs) have facilitated the creation of made tailored differentiation approaches, which have important uses in regenerative medicine. These advancements have enabled the implantation of hPSC-derived cell therapy products into patients, and the results of numerous ongoing clinical trials have been encouraging. A novel strategy for customized cell-based treatments for a range of human illnesses is ectopic expression of reprogramming factors, which allows adult somatic cells to be reprogrammed into induced pluripotent stem cells (IPSCs). The IPSCs technology is a useful tool for drug development and disease modelling, in addition to providing possible remedies. Similar to embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) are capable of genetic correction and can develop into any type of cell in the body. These features offer IPSCs a possible path way for the development of long-term treatments for a wide range of diseases that are currently incurable. Additionally, we review the potential uses of IPSCs and clinical examination of future cell culture strategies for large-scale production to improve patient accessibility. Keywords: Induced pluripotent stem cells (IPSCs), regenerative medicine, stem cell reprogramming, embryonic stem cells, and human pluripotent stem cell.